Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TVTXTravere Therapeutics, Inc.

Nasdaq · CIK 0001438533
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts619

Identity from submissions API

NameTravere Therapeutics, Inc.
CIK0001438533
TickersTVTX
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN262383102
LEI—
Fiscal year end1231
State of incorporationCA CA
Phone888-969-7879
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Retrophin, Inc. (2013-02-21T05:00:00.000Z → 2020-11-13T05:00:00.000Z)
  • Desert Gateway, Inc. (2008-06-27T04:00:00.000Z → 2013-02-19T05:00:00.000Z)
Business address
3611 VALLEY CENTRE DR
SUITE 300
SAN DIEGO
CA
92130
CA
Mailing address
3611 VALLEY CENTRE DR
SUITE 300
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1287 filing rows loaded from submissions recent; extra archives: CIK0001438533-submissions-001.json (286 filings, 2008-06-27 to 2015-10-07).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000070858-26-000590 005-87088 261556980 34 171743
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002862 005-87088 261526322 34 11840
2026-11-02 10-Q 10-Q 0001438533-26-000077 001-36257 261513145 34 9710627 1 1
2026-11-02 8-K 8-K 2.02,9.01 0001438533-26-000074 001-36257 261512301 34 431979 1 1
2026-10-19 4 xslF345X06/form4-10192026_041001.xml 0001763494-26-000008 16848
2026-10-15 144 xsl144X01/primary_doc.xml 0001950047-26-010273 001-36257 261463490 33 7225
2026-09-21 8-K 8-K 5.02,9.01 0001438533-26-000068 001-36257 261394058 34 505565 1 1
2026-09-17 4 xslF345X06/form4-09182026_010952.xml 0001698262-26-000005 32919
2026-09-17 4 xslF345X06/form4-09182026_010901.xml 0001789617-26-000004 42896
2026-09-17 4 xslF345X06/form4-09182026_010947.xml 0001902368-26-000008 14736
2026-09-17 4 xslF345X06/form4-09182026_010948.xml 0001283303-26-000010 14748
2026-09-17 4 xslF345X06/form4-09182026_010928.xml 0001763494-26-000007 29302
2026-09-17 4 xslF345X06/form4-09182026_010929.xml 0001943192-26-000006 14719
2026-09-17 4 xslF345X06/form4-09182026_010916.xml 0001882909-26-000004 20706
2026-09-17 144 xsl144X01/primary_doc.xml 0001950047-26-009642 001-36257 261387324 33 6485
2026-09-17 144 xsl144X01/primary_doc.xml 0001950047-26-009625 001-36257 261387215 33 6442
2026-09-16 144 xsl144X01/primary_doc.xml 0001950047-26-009577 001-36257 261384170 33 5723
2026-09-16 144 xsl144X01/primary_doc.xml 0001950047-26-009576 001-36257 261384168 33 5720
2026-09-16 144 xsl144X01/primary_doc.xml 0001950047-26-009566 001-36257 261384118 33 5748
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009523 001-36257 261381375 33 4960
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009521 001-36257 261381358 33 6465
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009520 001-36257 261381351 33 5584
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009513 001-36257 261381339 33 5011
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009510 001-36257 261381316 33 6324
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009503 001-36257 261381231 33 7025
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009488 001-36257 261381085 33 6315
2026-09-11 4 xslF345X06/form4-09112026_040911.xml 0001506916-26-000004 18710
2026-09-10 144 xsl144X01/primary_doc.xml 0001950047-26-009292 001-36257 261371568 33 4989
2026-09-03 4 xslF345X06/form4-09032026_040908.xml 0001943192-26-000005 5580
2026-08-19 4 xslF345X06/form4-08192026_040801.xml 0001123343-26-000010 20561
2026-08-18 144 xsl144X01/primary_doc.xml 0001950047-26-008327 001-36257 261291028 33 5750
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008242 001-36257 261287108 33 5032
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003621 005-87088 261277325 34 10815
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000070858-26-000437 005-87088 261266605 34 171760
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000546 005-87088 261252355 34 8303
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002183 005-87088 261247286 34 11922
2026-08-04 10-Q 10-Q 0001438533-26-000063 001-36257 261239645 34 10359358 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001438533-26-000062 001-36257 261238536 34 422621 1 1
2026-07-09 8-K 8-K 5.02 0001438533-26-000054 001-36257 261166355 34 152442 1 1
2026-06-22 4 xslF345X06/form4-06222026_080607.xml 0001902368-26-000007 5248
2026-06-17 S-8 S-8 0001438533-26-000052 333-296860 261099009 33 310224 1 1
2026-06-16 4 xslF345X06/form4-06162026_080644.xml 0001376043-26-000010 9416
2026-06-16 4 xslF345X06/form4-06162026_080649.xml 0001680739-26-000014 8940
2026-06-16 8-K 8-K 5.02 0001438533-26-000048 001-36257 261095131 34 151806 1 1
2026-06-12 144 xsl144X01/primary_doc.xml 0001950047-26-005979 001-36257 261086508 33 8013
2026-06-12 144 xsl144X01/primary_doc.xml 0001376043-26-000007 001-36257 261085647 33 5347
2026-06-02 8-K 8-K 1.01,9.01 0001193125-26-252474 001-36257 261053585 34 155603 1 1
2026-05-21 4 xslF345X06/form4-05212026_050518.xml 0001344381-26-000004 7711
2026-05-21 4 xslF345X06/form4-05212026_050515.xml 0001454001-26-000002 7502
2026-05-21 4 xslF345X06/form4-05212026_050514.xml 0001619622-26-000002 7504
2026-05-21 4 xslF345X06/form4-05212026_050512.xml 0001477384-26-000008 7474
2026-05-21 4 xslF345X06/form4-05212026_050510.xml 0001506916-26-000003 7501
2026-05-21 4 xslF345X06/form4-05212026_050508.xml 0001123343-26-000004 7546
2026-05-21 4 xslF345X06/form4-05212026_050506.xml 0001376043-26-000006 7662
2026-05-21 4 xslF345X06/form4-05212026_050504.xml 0001517790-26-000002 7520
2026-05-21 4 xslF345X06/form4-05212026_050501.xml 0001680739-26-000012 7478
2026-05-21 8-K 8-K 5.02,5.07,9.01 0001438533-26-000046 001-36257 261008423 34 435242 1 1
2026-05-19 4 xslF345X06/form4-05192026_040501.xml 0001376043-26-000005 5357
2026-05-15 144 xsl144X01/primary_doc.xml 0001376043-26-000004 001-36257 26985015 33 4702
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002146 005-87088 26984135 34 10619
2026-05-11 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001193125-26-217100 001-36257 26964407 34 1612218 1 1
2026-05-07 424B5 424B5 0001193125-26-211968 333-281194 26953601 33 1675696 1 1
2026-05-07 305B2 305B2 0001193125-26-211832 333-281194 26952955 33 264916
2026-05-07 FWP FWP 0001193125-26-210121 333-281194 26950577 34 49324
2026-05-06 4 xslF345X06/form4-05062026_080518.xml 0001680739-26-000008 8942
2026-05-06 4 xslF345X06/form4-05062026_080516.xml 0001506916-26-000001 9018
2026-05-06 4 xslF345X06/form4-05062026_080513.xml 0001698262-26-000004 12414
2026-05-06 4 xslF345X06/form4-05062026_080511.xml 0001283303-26-000009 19967
2026-05-06 4 xslF345X06/form4-05062026_080509.xml 0001902368-26-000006 20007
2026-05-06 4 xslF345X06/form4-05062026_080506.xml 0001789617-26-000003 12642
2026-05-06 4 xslF345X06/form4-05062026_080504.xml 0001763494-26-000006 12372
2026-05-06 4 xslF345X06/form4-05062026_080501.xml 0001943192-26-000004 14496
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004102 001-36257 26948191 33 8827
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004101 001-36257 26948187 33 11091
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004100 001-36257 26948181 33 8030
2026-05-06 144 xsl144X01/primary_doc.xml 0001959173-26-003309 001-36257 26946315 33 6524
2026-05-06 144 xsl144X01/primary_doc.xml 0001959173-26-003306 001-36257 26946274 33 5304
2026-05-05 144 xsl144X01/primary_doc.xml 0001193125-26-207099 001-36257 26945325 33 7717
2026-05-05 144 xsl144X01/primary_doc.xml 0001193125-26-207083 001-36257 26945293 33 9736
2026-05-05 144 xsl144X01/primary_doc.xml 0001193125-26-207080 001-36257 26945290 33 7003
2026-05-05 144 xsl144X01/primary_doc.xml 0001193125-26-207078 001-36257 26945289 33 5661
2026-05-05 144 xsl144X01/primary_doc.xml 0001950047-26-004082 001-36257 26944253 33 7261
2026-05-05 424B5 424B5 0001193125-26-206334 333-281194 26942910 33 1511236
2026-05-04 10-Q 10-Q 0001438533-26-000042 001-36257 26938576 34 8819412 1 1
2026-05-04 4 xslF345X06/form4-05042026_080519.xml 0001680739-26-000007 8943
2026-05-04 8-K 8-K 2.02,9.01 0001438533-26-000041 001-36257 26937526 34 378543 1 1
2026-05-04 144 xsl144X01/primary_doc.xml 0001950047-26-003951 001-36257 26937435 33 9576
2026-05-04 144 xsl144X01/primary_doc.xml 0001950047-26-003950 001-36257 26937430 33 5027
2026-05-04 144 xsl144X01/primary_doc.xml 0001950047-26-003946 001-36257 26937401 33 6525
2026-05-01 144 xsl144X01/primary_doc.xml 0001950047-26-003899 001-36257 26932716 33 6510
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001151 005-87088 26923159 34 7617
2026-04-23 4 xslF345X06/form4-04232026_040401.xml 0001698262-26-000003 5353
2026-04-22 144 xsl144X01/primary_doc.xml 0001959173-26-003030 001-36257 26881782 33 5310
2026-04-16 4 xslF345X06/form4-04162026_040407.xml 0001123343-26-000002 9050
2026-04-16 4 xslF345X06/form4-04162026_040405.xml 0001680739-26-000005 24798
2026-04-16 4 xslF345X06/form4-04162026_040403.xml 0001882909-26-000003 16713
2026-04-15 4 xslF345X06/form4-04162026_010423.xml 0001789617-26-000002 7395
2026-04-15 4 xslF345X06/form4-04162026_010440.xml 0001698262-26-000002 5321
2026-04-15 4 xslF345X06/form4-04162026_010408.xml 0001763494-26-000005 10901
2026-04-15 4 xslF345X06/form4-04162026_010431.xml 0001283303-26-000008 24206
2026-04-15 4 xslF345X06/form4-04162026_010454.xml 0001943192-26-000003 13140
2026-04-15 4 xslF345X06/form4-04162026_010435.xml 0001902368-26-000005 9232
2026-04-15 144 xsl144X01/primary_doc.xml 0001959173-26-002926 001-36257 26864351 33 7796
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003482 001-36257 26864338 33 11091
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003478 001-36257 26864295 33 8829
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003477 001-36257 26864291 33 7280
2026-04-14 144 xsl144X01/primary_doc.xml 0001193125-26-155628 001-36257 26862319 33 9735
2026-04-14 144 xsl144X01/primary_doc.xml 0001193125-26-155560 001-36257 26862285 33 6327
2026-04-14 144 xsl144X01/primary_doc.xml 0001193125-26-155537 001-36257 26862276 33 5661
2026-04-14 144 xsl144X01/primary_doc.xml 0001193125-26-155495 001-36257 26862267 33 7717
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003429 001-36257 26861122 33 5028
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003426 001-36257 26861048 33 7309
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003425 001-36257 26861040 33 9575
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003420 001-36257 26860928 33 5760
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003416 001-36257 26860833 33 6938
2026-04-14 8-K 8-K 8.01 0001438533-26-000032 001-36257 26858937 34 162651 1 1
2026-04-13 144 xsl144X01/primary_doc.xml 0001193125-26-153378 001-36257 26858890 33 6333
2026-04-07 4 xslF345X06/form4-04072026_100418.xml 0001680739-26-000003 8957
2026-04-06 ARS ARS 0001438533-26-000029 001-36257 26841296 34 53950898
2026-04-06 DEFA14A DEFA14A 0001438533-26-000028 001-36257 26841270 34 63962
2026-04-06 DEF 14A DEF 14A 0001438533-26-000027 001-36257 26841245 34 4133291 1 1
2026-04-06 144 xsl144X01/primary_doc.xml 0001950047-26-003230 001-36257 26841209 33 5007
2026-04-02 4 xslF345X06/form4-04022026_050410.xml 0001763494-26-000004 11234
2026-04-02 4 xslF345X06/form4-04022026_050408.xml 0001283303-26-000007 9015
2026-04-01 144 xsl144X01/primary_doc.xml 0001959173-26-002715 001-36257 26828311 33 7074
2026-04-01 144 xsl144X01/primary_doc.xml 0001950047-26-003118 001-36257 26828167 33 8818
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002431 005-87088 26804819 34 7382
2026-03-18 4 xslF345X06/form4-03182026_040301.xml 0001283303-26-000006 9377
2026-03-16 144 xsl144X01/primary_doc.xml 0001950047-26-002635 001-36257 26757026 33 8062
2026-02-24 4 xslF345X05/form4-02242026_040201.xml 0001763494-26-000003 9108
2026-02-20 144 xsl144X01/primary_doc.xml 0001959173-26-001307 001-36257 26660901 33 6409
2026-02-19 10-K 10-K 0001438533-26-000014 001-36257 26655251 34 14226087 1 1
2026-02-19 4 xslF345X05/form4-02192026_040201.xml 0001283303-26-000005 11204
2026-02-19 8-K 8-K 2.02,9.01 0001438533-26-000013 001-36257 26654324 34 375630 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001227 005-87088 26645053 34 10720
2026-02-17 144 xsl144X01/primary_doc.xml 0001950047-26-001339 001-36257 26642150 33 7306
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054520 005-87088 26640550 34 10985
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-049707 005-87088 26628731 34 205550
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000092 005-87088 26609683 34 8195
2026-02-05 4 xslF345X05/form4-02052026_040203.xml 0001902368-26-000004 7453
2026-02-05 4 xslF345X05/form4-02052026_040201.xml 0001943192-26-000002 7099
2026-02-05 4 xslF345X05/form4-02052026_040205.xml 0001283303-26-000003 7459
2026-02-04 144 xsl144X01/primary_doc.xml 0001950047-26-000918 001-36257 26598233 33 6554
2026-02-04 144 xsl144X01/primary_doc.xml 0001950047-26-000917 001-36257 26598219 33 8028
2026-02-04 144 xsl144X01/primary_doc.xml 0001950047-26-000904 001-36257 26598064 33 6565
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-036557 001-36257 26595905 33 5634
2026-02-03 144 xsl144X01/primary_doc.xml 0001193125-26-036479 001-36257 26595902 33 5612
2026-02-03 144 xsl144X01/primary_doc.xml 0001193125-26-036474 001-36257 26595897 33 6967
2026-02-03 144 xsl144X01/primary_doc.xml 0001193125-26-036459 001-36257 26595873 33 5659
2026-02-03 144 xsl144X01/primary_doc.xml 0001193125-26-036456 001-36257 26595848 33 6977
2026-02-03 4 xslF345X05/form4-02032026_090212.xml 0001763494-26-000002 11451
2026-02-03 4 xslF345X05/form4-02032026_090210.xml 0001902368-26-000003 9456
2026-02-03 4 xslF345X05/form4-02032026_090208.xml 0001943192-26-000001 9474
2026-02-03 4 xslF345X05/form4-02032026_090207.xml 0001789617-26-000001 9463
2026-02-03 4 xslF345X05/form4-02032026_090205.xml 0001698262-26-000001 9236
2026-02-03 4 xslF345X05/form4-02032026_090201.xml 0001882909-26-000001 9436
2026-02-03 4 xslF345X05/form4-02032026_090203.xml 0001283303-26-000002 9453
2026-02-03 144 xsl144X01/primary_doc.xml 0001959173-26-000570 001-36257 26590954 33 5887
2026-02-03 144 xsl144X01/primary_doc.xml 0001959173-26-000560 001-36257 26590520 33 5306
2026-01-27 4 xslF345X05/form4-01282026_010144.xml 0001763494-26-000001 14594
2026-01-27 144 xsl144X01/primary_doc.xml 0001959173-26-000458 001-36257 26565461 33 6515
2026-01-23 144 xsl144X01/primary_doc.xml 0001959173-26-000432 001-36257 26556582 33 5945
2026-01-21 4 xslF345X05/form4-01212026_040109.xml 0001283303-26-000001 9495
2026-01-20 144 xsl144X01/primary_doc.xml 0001950047-26-000541 001-36257 26542804 33 5041
2026-01-13 8-K 8-K 8.01 0001438533-26-000005 001-36257 26530461 34 161495 1 1
2026-01-12 8-K 8-K 2.02,9.01 0001438533-26-000003 001-36257 26527630 34 222475 1 1
2026-01-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000051 005-87088 26517684 34 11732
2026-01-07 4 xslF345X05/form4-01072026_040106.xml 0001902368-26-000002 7254
2026-01-06 144 xsl144X01/primary_doc.xml 0001950047-26-000175 001-36257 26511476 33 6526
2026-01-05 144 xsl144X01/primary_doc.xml 0001193125-26-003062 001-36257 26508904 33 5629
2025-12-29 4 xslF345X05/form4-12302025_021236.xml 0001789617-25-000009 5083
2025-12-29 4 xslF345X05/form4-12302025_021233.xml 0001698262-25-000005 9638
2025-12-29 4 xslF345X05/form4-12302025_021222.xml 0001902368-25-000005 9301
2025-12-29 4 xslF345X05/form4-12302025_011208.xml 0001882909-25-000008 5057
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010715 001-36257 251604366 33 5267
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010713 001-36257 251604354 33 9116
2025-12-29 144 xsl144X01/primary_doc.xml 0001959173-25-007920 001-36257 251602892 33 6469
2025-12-29 144 xsl144X01/primary_doc.xml 0001959173-25-007916 001-36257 251602709 33 4663
2025-12-16 4 xslF345X05/form4-12162025_091205.xml 0001882909-25-000006 5057
2025-12-15 144 xsl144X01/primary_doc.xml 0001950047-25-010276 001-36257 251571584 33 5758
2025-12-03 4 xslF345X05/form4-12032025_041209.xml 0001943192-25-000005 9313
2025-12-01 144 xsl144X01/primary_doc.xml 0001950047-25-009511 001-36257 251539728 33 6557
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005160 005-87088 251488689 34 10911
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000318 005-87088 251483736 34 9749
2025-11-06 4 xslF345X05/form4-11062025_041101.xml 0001882909-25-000004 23860
2025-11-04 144 xsl144X01/primary_doc.xml 0001950047-25-008434 001-36257 251449218 33 9122
2025-11-04 4 xslF345X05/form4-11042025_041110.xml 0001376043-25-000004 12855
2025-11-04 4 xslF345X05/form4-11042025_041108.xml 0001789617-25-000007 6895
2025-10-31 144 xsl144X01/primary_doc.xml 0001957799-25-000224 001-36257 251440504 33 4679
2025-10-31 144 xsl144X01/primary_doc.xml 0001959173-25-006629 001-36257 251440159 33 6908
2025-10-30 10-Q 10-Q 0001438533-25-000056 001-36257 251436637 34 9078566 1 1
2025-10-30 4 xslF345X05/form4-10302025_041004.xml 0001763494-25-000005 14599
2025-10-30 4 xslF345X05/form4-10302025_041001.xml 0001789617-25-000006 5083
2025-10-30 8-K 8-K 2.02,9.01 0001438533-25-000055 001-36257 251435503 34 426369 1 1
2025-10-29 144 xsl144X01/primary_doc.xml 0001959173-25-006603 001-36257 251430368 33 5209
2025-10-28 144 xsl144X01/primary_doc.xml 0001959173-25-006592 001-36257 251425650 33 4601
2025-10-28 144 xsl144X01/primary_doc.xml 0001959173-25-006585 001-36257 251423299 33 5200
2025-10-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-238357 005-87088 251390038 34 303513
2025-09-24 4 xslF345X05/form4-09242025_040905.xml 0001789617-25-000004 5180
2025-09-24 4 xslF345X05/form4-09242025_040903.xml 0001283303-25-000005 9098
2025-09-22 144 xsl144X01/primary_doc.xml 0001950047-25-007388 001-36257 251330034 33 5042
2025-09-10 8-K 8-K 8.01 0001438533-25-000049 001-36257 251304655 34 161635 1 1
2025-09-05 4 xslF345X05/form4-09052025_040901.xml 0001415889-25-023786 7272
2025-08-28 4 xslF345X05/form4-08282025_040801.xml 0001415889-25-023209 5272
2025-08-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003635 005-87088 251223558 34 10867
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000194 005-87088 251192300 34 9749
2025-08-06 10-Q 10-Q 0001438533-25-000046 001-36257 251190679 34 9025137 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001438533-25-000045 001-36257 251189521 34 418149 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-001051 005-87088 251160687 34 6424
2025-07-02 4 xslF345X05/form4-07022025_090753.xml 0001415889-25-019108 5261
2025-06-17 S-8 S-8 0001438533-25-000038 333-288114 251054253 33 307980 1 1
2025-05-16 4 xslF345X05/form4-05162025_070518.xml 0001415889-25-013504 7573
2025-05-16 4 xslF345X05/form4-05162025_070517.xml 0001415889-25-013503 7353
2025-05-16 4 xslF345X05/form4-05162025_070515.xml 0001415889-25-013502 7302
2025-05-16 4 xslF345X05/form4-05162025_070513.xml 0001415889-25-013501 7336
2025-05-16 4 xslF345X05/form4-05162025_070511.xml 0001415889-25-013500 7331
2025-05-16 4 xslF345X05/form4-05162025_070509.xml 0001415889-25-013499 7404
2025-05-16 4 xslF345X05/form4-05162025_070507.xml 0001415889-25-013498 7412
2025-05-16 4 xslF345X05/form4-05162025_070505.xml 0001415889-25-013497 7380
2025-05-16 4 xslF345X05/form4-05162025_070503.xml 0001415889-25-013496 7353
2025-05-16 8-K 8-K 5.02,5.07,9.01 0001438533-25-000034 001-36257 25959397 34 440793 1 1
2025-05-15 8-K 8-K 8.01 0001438533-25-000032 001-36257 25954014 34 168932 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002216 005-87088 25951813 34 10867
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002075 005-87088 25949902 34 14836
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-071930 005-87088 25948463 34 244190
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000125 005-87088 25943766 34 9619
2025-05-05 4 xslF345X05/form4-05062025_010528.xml 0001415889-25-012061 9760
2025-05-05 4 xslF345X05/form4-05062025_010542.xml 0001415889-25-012058 9474
2025-05-05 4 xslF345X05/form4-05062025_010504.xml 0001415889-25-012057 9749
2025-05-05 4 xslF345X05/form4-05062025_010518.xml 0001415889-25-012056 9523
2025-05-05 4 xslF345X05/form4-05062025_010531.xml 0001415889-25-012054 9449
2025-05-05 144 xsl144X01/primary_doc.xml 0000950170-25-063806 001-36257 25914718 33 6357
2025-05-05 144 xsl144X01/primary_doc.xml 0000950170-25-063804 001-36257 25914711 33 7021
2025-05-05 144 xsl144X01/primary_doc.xml 0001959173-25-002858 001-36257 25911677 33 5251
2025-05-05 144 xsl144X01/primary_doc.xml 0001959173-25-002857 001-36257 25911622 33 5247
2025-05-05 144 xsl144X01/primary_doc.xml 0001959173-25-002850 001-36257 25911399 33 5307
2025-05-01 8-K/A 8-K/A 2.02,9.01 0001438533-25-000030 001-36257 25904439 34 378491 1 1
2025-05-01 10-Q 10-Q 0001438533-25-000026 001-36257 25903982 34 8249747 1 1
2025-05-01 8-K 8-K 2.01,9.01 0001438533-25-000025 001-36257 25903009 34 377364 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000623 005-87088 25892281 34 6421
2025-04-30 8-K 8-K 8.01 0001438533-25-000020 001-36257 25889772 34 166154 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000661 005-87088 25844617 34 11257
2025-04-14 4 xslF345X05/form4-04142025_100426.xml 0001415889-25-010643 5442
2025-04-11 144 xsl144X01/primary_doc.xml 0000950170-25-053412 001-36257 25833874 33 6331
2025-04-01 ARS ARS 0001438533-25-000018 001-36257 25799696 34 1900387
2025-04-01 DEFA14A DEFA14A 0001438533-25-000017 001-36257 25799672 34 130835
2025-04-01 DEF 14A DEF 14A 0001438533-25-000016 001-36257 25799649 34 4134529 1 1
2025-03-17 8-K 8-K 8.01 0001438533-25-000012 001-36257 25745381 34 168761 1 1
2025-02-21 10-K 10-K 0001438533-25-000010 001-36257 25648184 34 14568109 1 1
2025-02-20 8-K 8-K 2.02,9.01 0001438533-25-000008 001-36257 25645205 34 387987 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001271 005-87088 25631059 34 10884
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001022 005-87088 25628445 34 9136
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000906 005-87088 25623775 34 14656
2025-02-12 4 xslF345X05/form4-02132025_020257.xml 0001415889-25-003824 9530
2025-02-12 4 xslF345X05/form4-02132025_020224.xml 0001415889-25-003823 9468
2025-02-12 4 xslF345X05/form4-02132025_020258.xml 0001415889-25-003822 27009
2025-02-12 4 xslF345X05/form4-02132025_020229.xml 0001415889-25-003821 11475
2025-02-12 4 xslF345X05/form4-02132025_020239.xml 0001415889-25-003820 5044
2025-02-12 4 xslF345X05/form4-02132025_020211.xml 0001415889-25-003819 9753
2025-02-12 144 xsl144X01/primary_doc.xml 0000950170-25-019188 001-36257 25616723 33 7016
2025-02-12 144 xsl144X01/primary_doc.xml 0000950170-25-019185 001-36257 25616711 33 7676
2025-02-12 144 xsl144X01/primary_doc.xml 0001959173-25-000907 001-36257 25613148 33 5940
2025-02-12 144 xsl144X01/primary_doc.xml 0001959173-25-000901 001-36257 25612736 33 5896
2025-02-11 144 xsl144X01/primary_doc.xml 0001950047-25-000746 001-36257 25609828 33 9514
2025-02-11 144 xsl144X01/primary_doc.xml 0001950047-25-000744 001-36257 25609722 33 7134
2025-02-11 144 xsl144X01/primary_doc.xml 0001959173-25-000867 001-36257 25608438 33 5812
2025-02-11 8-K 8-K 8.01 0001438533-25-000004 001-36257 25607660 34 164728 1 1
2025-02-10 4 xslF345X05/form4-02102025_110214.xml 0001415889-25-003529 8882
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-015862 005-87088 25599328 34 405272
2025-02-06 144 xsl144X01/primary_doc.xml 0001950047-25-000648 001-36257 25597685 33 5783
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001251 005-87088 25592255 34 12286
2025-02-04 4 xslF345X05/form4-02042025_080224.xml 0001415889-25-003067 9239
2025-02-04 4 xslF345X05/form4-02042025_080220.xml 0001415889-25-003066 9177
2025-02-04 4 xslF345X05/form4-02042025_080216.xml 0001415889-25-003065 9574
2025-02-04 4 xslF345X05/form4-02042025_080213.xml 0001415889-25-003064 11296
2025-02-04 4 xslF345X05/form4-02042025_080209.xml 0001415889-25-003063 9469
2025-02-04 4 xslF345X05/form4-02042025_080206.xml 0001415889-25-003062 9478
2025-02-04 4 xslF345X05/form4-02042025_080201.xml 0001415889-25-003061 9442
2025-02-04 144 xsl144X01/primary_doc.xml 0001950047-25-000601 001-36257 25588260 33 7281
2025-02-03 144 xsl144X01/primary_doc.xml 0000950170-25-012658 001-36257 25584728 33 5643
2025-02-03 144 xsl144X01/primary_doc.xml 0000950170-25-012655 001-36257 25584725 33 5663
2025-02-03 144 xsl144X01/primary_doc.xml 0000950170-25-012650 001-36257 25584715 33 6969
2025-02-03 144 xsl144X01/primary_doc.xml 0000950170-25-012649 001-36257 25584712 33 5633
2025-02-03 144 xsl144X01/primary_doc.xml 0001959173-25-000613 001-36257 25581479 33 5256
2025-02-03 144 xsl144X01/primary_doc.xml 0001959173-25-000603 001-36257 25581166 33 5321
2025-02-03 144 xsl144X01/primary_doc.xml 0001959173-25-000596 001-36257 25581049 33 5303
2025-01-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000267 005-87088 25576421 34 6479
2025-01-23 4 xslF345X05/form4-01242025_010159.xml 0001415889-25-002008 5394
2025-01-23 4 xslF345X05/form4-01242025_010157.xml 0001415889-25-002006 5162
2025-01-23 4 xslF345X05/form4-01242025_010150.xml 0001415889-25-002004 5331
2025-01-23 4 xslF345X05/form4-01242025_010152.xml 0001415889-25-002003 8884
2025-01-23 4 xslF345X05/form4-01242025_010141.xml 0001415889-25-002001 5441
2025-01-23 4 xslF345X05/form4-01242025_010121.xml 0001415889-25-001999 5450
2025-01-23 4 xslF345X05/form4-01242025_010158.xml 0001415889-25-001997 5414
2025-01-23 144 xsl144X01/primary_doc.xml 0001950047-25-000396 001-36257 25550284 33 5029
2025-01-22 144 xsl144X01/primary_doc.xml 0001959173-25-000412 001-36257 25544221 33 4617
2025-01-22 144 xsl144X01/primary_doc.xml 0001959173-25-000411 001-36257 25544173 33 4613
2025-01-22 144 xsl144X01/primary_doc.xml 0001959173-25-000402 001-36257 25544068 33 4661
2025-01-13 8-K 8-K 2.02,9.01 0001438533-25-000002 001-36257 25524805 34 232985 1 1
2025-01-06 4 xslF345X05/form4-01072025_120158.xml 0001415889-25-000899 7267
2024-12-27 4 xslF345X05/form4-12282024_121201.xml 0001415889-24-030210 9190
2024-12-26 144 xsl144X01/primary_doc.xml 0001950047-24-010073 001-36257 241581224 33 5771
2024-11-25 4 xslF345X05/form4-11262024_021145.xml 0001415889-24-027672 9297
2024-11-25 144 xsl144X01/primary_doc.xml 0001972362-24-001739 001-36257 241497531 33 4455
2024-11-14 SC 13G/A armistice-tvtx093024a3.htm 0001172661-24-005319 005-87088 241464249 34 90950
2024-11-14 SC 13G TRAVERE THERAPEUTICS, INC. 0000902664-24-006574 005-87088 241459662 34 50629
2024-11-14 SC 13G/A deeptrack-tvtx093024a3.htm 0001172661-24-004777 005-87088 241457911 34 103346
2024-11-12 SC 13G/A UnitedStates_13G__TravereThe.txt 0000932471-24-001276 005-87088 241450288 34 6767
2024-11-08 SC 13G/A MS AMENDMENT 0000895421-24-000641 005-87088 241441514 34 13053
2024-11-08 8-K 8-K 8.01,9.01 0001193125-24-254153 001-36257 241440731 34 510907 1 1
2024-11-08 424B5 424B5 0001193125-24-254147 333-281194 241440675 33 729074 1 1
2024-11-07 424B5 424B5 0001193125-24-253102 333-281194 241435360 33 575305
2024-11-04 SC 13G/A UnitedStates_13G__TravereThe.txt 0000932471-24-000711 005-87088 241422463 34 5811
2024-10-31 424B5 424B5 0001438533-24-000050 333-281194 241412611 33 540377 1 1
2024-10-31 10-Q 10-Q 0001438533-24-000048 001-36257 241412601 34 9989224 1 1
2024-10-31 8-K 8-K 2.02,9.01 0001438533-24-000046 001-36257 241412531 34 421489 1 1
2024-10-18 SC 13G/A Travere_Therapeutics_Inc.htm 0000093751-24-000882 005-87088 241379476 34 56157
2024-10-04 4 xslF345X05/form4-10042024_111048.xml 0001415889-24-024795 11209
2024-10-04 144 xsl144X01/primary_doc.xml 0001950047-24-007584 001-36257 241355171 33 5034
2024-09-30 4 xslF345X05/form4-10012024_121008.xml 0001415889-24-024117 9248
2024-09-30 144 xsl144X01/primary_doc.xml 0001950047-24-007453 001-36257 241339780 33 5005
2024-09-26 8-K 8-K 8.01 0001438533-24-000038 001-36257 241328810 34 164488 1 1
2024-09-11 144 xsl144X01/primary_doc.xml 0001972362-24-001327 001-36257 241293510 33 4455
2024-09-10 4 xslF345X05/form4-09102024_040901.xml 0001415889-24-023128 5244
2024-09-09 4 xslF345X05/form4-09092024_090913.xml 0001415889-24-023096 7395
2024-09-09 4 xslF345X05/form4-09092024_090911.xml 0001415889-24-023095 7103
2024-09-09 4 xslF345X05/form4-09092024_090909.xml 0001415889-24-023094 7123
2024-09-09 4 xslF345X05/form4-09092024_090907.xml 0001415889-24-023093 7390
2024-09-09 4 xslF345X05/form4-09092024_090904.xml 0001415889-24-023092 7630
2024-09-09 4 xslF345X05/form4-09092024_090901.xml 0001415889-24-023091 7408
2024-09-09 144 xsl144X01/primary_doc.xml 0001959173-24-006328 001-36257 241286300 33 4621
2024-09-09 144 xsl144X01/primary_doc.xml 0001959173-24-006326 001-36257 241286227 33 4662
2024-09-09 144 xsl144X01/primary_doc.xml 0001959173-24-006325 001-36257 241286225 33 4619
2024-09-06 8-K 8-K 8.01,9.01 0001438533-24-000035 001-36257 241282376 34 175857 1 1
2024-09-05 4 xslF345X05/form4-09052024_090901.xml 0001415889-24-022992 5450
2024-08-01 S-3ASR S-3ASR 0001193125-24-191647 333-281194 241167996 33 1198479 1 1
2024-08-01 10-Q 10-Q 0001438533-24-000031 001-36257 241167408 34 9387392 1 1
2024-08-01 8-K 8-K 2.02,9.01 0001438533-24-000030 001-36257 241166565 34 404200 1 1
2024-06-14 S-8 S-8 0001438533-24-000025 333-280213 241044727 33 170380
2024-05-13 8-K 8-K 5.02,5.07,9.01 0001438533-24-000022 001-36257 24938982 34 443937 1 1
2024-05-10 4 xslF345X05/form4-05102024_040553.xml 0001415889-24-012851 7351
2024-05-10 4 xslF345X05/form4-05102024_040555.xml 0001415889-24-012852 7571
2024-05-10 4 xslF345X05/form4-05102024_040541.xml 0001415889-24-012849 7334
2024-05-10 4 xslF345X05/form4-05102024_040548.xml 0001415889-24-012850 7300
2024-05-10 4 xslF345X05/form4-05102024_040536.xml 0001415889-24-012848 7329
2024-05-10 4 xslF345X05/form4-05102024_040530.xml 0001415889-24-012847 7402
2024-05-10 4 xslF345X05/form4-05102024_040522.xml 0001415889-24-012846 7410
2024-05-10 4 xslF345X05/form4-05102024_040513.xml 0001415889-24-012845 7369
2024-05-10 4 xslF345X05/form4-05102024_040510.xml 0001415889-24-012844 7351
2024-05-06 10-Q 10-Q 0001438533-24-000020 001-36257 24918271 34 9242996 1 1
2024-05-06 8-K 8-K 2.02,9.01 0001438533-24-000019 001-36257 24917479 34 373317 1 1
2024-05-01 SC 13G rocksprings-tvtx042524.htm 0001172661-24-001968 005-87088 24903122 34 110485
2024-04-24 8-K 8-K 8.01,9.01 0001438533-24-000016 001-36257 24870544 34 168146 1 1
2024-04-12 4 xslF345X05/form4-04122024_040401.xml 0001415889-24-010754 5446
2024-03-27 ARS ARS 0001438533-24-000014 001-36257 24791369 34 2734615
2024-03-27 DEFA14A DEFA14A 0001438533-24-000013 001-36257 24791326 34 129852
2024-03-27 DEF 14A DEF 14A 0001438533-24-000012 001-36257 24791275 34 2482486 1 1
2024-02-23 8-K 8-K 8.01,9.01 0001438533-24-000007 001-36257 24671122 34 170380 1 1
2024-02-20 10-K 10-K 0001438533-24-000005 001-36257 24650861 34 15448727 1 1
2024-02-15 8-K 8-K 2.02,9.01 0001438533-24-000003 001-36257 24643780 34 382603 1 1
2024-02-14 SC 13G/A armistice-tvtx123123a2.htm 0001172661-24-001245 005-87088 24636188 34 90923
2024-02-14 SC 13G/A deeptrack-tvtx123123a2.htm 0001172661-24-000946 005-87088 24632745 34 105162
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-034915 005-87088 24632080 34 106043
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022126 005-87088 24629830 34 13269
2024-02-12 SC 13G/A JHG PLC OWNS <5% 0001274173-24-000013 005-87088 24619338 34 10329
2024-02-09 SC 13G MS INITIAL 0000895421-24-000110 005-87088 24612818 34 12903
2024-02-07 SC 13G/A TRAVERE THERAPEUTICS, INC. 0000902664-24-001160 005-87088 24602178 34 101283
2024-02-02 4 xslF345X05/form4-02022024_040236.xml 0001415889-24-002285 11230
2024-02-02 4 xslF345X05/form4-02022024_040225.xml 0001415889-24-002284 11271
2024-02-02 4 xslF345X05/form4-02022024_040202.xml 0001415889-24-002279 11333
2024-02-02 4 xslF345X05/form4-02022024_040213.xml 0001415889-24-002283 11210
2024-02-02 4 xslF345X05/form4-02022024_040211.xml 0001415889-24-002282 9853
2024-02-02 4 xslF345X05/form4-02022024_040208.xml 0001415889-24-002281 9460
2024-02-02 4 xslF345X05/form4-02022024_040206.xml 0001415889-24-002280 9863
2024-02-01 144 xsl144X01/primary_doc.xml 0000950170-24-009992 001-36257 24588654 33 6318
2024-02-01 144 xsl144X01/primary_doc.xml 0000950170-24-009991 001-36257 24588653 33 6241
2024-02-01 144 xsl144X01/primary_doc.xml 0000950170-24-009990 001-36257 24588651 33 5642
2024-02-01 144 xsl144X01/primary_doc.xml 0000950170-24-009988 001-36257 24588648 33 6325
2024-02-01 144 xsl144X01/primary_doc.xml 0001959173-24-000557 001-36257 24585866 33 5317
2024-02-01 144 xsl144X01/primary_doc.xml 0001959173-24-000553 001-36257 24585664 33 5226
2024-02-01 144 xsl144X01/primary_doc.xml 0001959173-24-000539 001-36257 24585290 33 5299
2024-01-25 4 xslF345X05/form4-01252024_040109.xml 0001415889-24-001801 5120
2024-01-25 4 xslF345X05/form4-01252024_040107.xml 0001415889-24-001799 5133
2024-01-25 4 xslF345X05/form4-01252024_040102.xml 0001415889-24-001798 5449
2024-01-25 4 xslF345X05/form4-01252024_040111.xml 0001415889-24-001800 5413
2024-01-25 4 xslF345X05/form4-01252024_040102.xml 0001415889-24-001796 5413
2024-01-25 4 xslF345X05/form4-01252024_040105.xml 0001415889-24-001797 5439
2024-01-25 SC 13G/A Travere_Therap_Inc.txt 0000093751-24-000210 005-87088 24559144 34 10603
2024-01-24 SC 13G/A us89422g1076_012324.txt 0001086364-24-002023 005-87088 24554615 34 13891
2024-01-23 144 xsl144X01/primary_doc.xml 0001959173-24-000418 001-36257 24551811 33 4680
2024-01-23 144 xsl144X01/primary_doc.xml 0001959173-24-000411 001-36257 24550949 33 4624
2024-01-23 144 xsl144X01/primary_doc.xml 0001959173-24-000410 001-36257 24550939 33 4670
2024-01-08 8-K FORM 8-K 2.02,9.01 0001193125-24-003866 001-36257 24518303 34 197906 1 1
2024-01-05 4 FORM 4 SUBMISSION 0001209191-24-001005 7341
2023-12-04 8-K 8-K 2.05,8.01,9.01 0001438533-23-000050 001-36257 231463119 34 176818 1 1
2023-11-07 10-Q 10-Q 0001438533-23-000048 001-36257 231385081 34 9277552 1 1
2023-11-07 8-K 8-K 2.02,9.01 0001438533-23-000046 001-36257 231383610 34 428769 1 1
2023-10-06 SC 13G/A us89422g1076_100523.txt 0001306550-23-010082 005-87088 231313921 34 13801
2023-10-04 4 FORM 4 SUBMISSION 0001209191-23-051885 5638
2023-09-21 8-K 8-K 8.01 0001193125-23-239098 001-36257 231267744 34 323517 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (619 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 95.99M 2026-10-28 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
dei EntityNumberOfEmployees Entity Number of Employees Employee 135 2016-09-30 2016 Q3 10-Q 2016-11-04 0001628280-16-020847
dei EntityPublicFloat Entity Public Float USD 1.31B 2025-06-30 2025 FY 10-K 2026-02-19 0001438533-26-000014
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 410.46M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 6.03M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.45M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 24.50M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ecd PeoTotalCompAmt PeoTotalCompAmt USD 8.46M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 140.19 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001438533-26-000027
ffd NetFeeAmt NetFeeAmt USD 72,502.5 2026-05-07 424B5 2026-05-07 0001193125-26-211968
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 525.00M 2026-05-07 424B5 2026-05-07 0001193125-26-211968
ffd TtlFeeAmt TtlFeeAmt USD 72,502.5 2026-05-07 424B5 2026-05-07 0001193125-26-211968
ffd TtlOfferingAmt TtlOfferingAmt USD 525.00M 2026-05-07 424B5 2026-05-07 0001193125-26-211968
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-07 424B5 2026-05-07 0001193125-26-211968
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-07 424B5 2026-05-07 0001193125-26-211968
invest InvestmentInterestRate Investment Interest Rate pure 0.12 2012-02-02 2012-02-03 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities (Deprecated 2009-01-31) USD 2,000 2012-02-29 2011 FY 10-K 2012-05-24 0001225279-12-000073
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 15.28M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 10,000 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap AccountsPayableTrade Accounts Payable, Trade (Deprecated 2009-01-31) USD 750 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 750 2012-11-30 2012 Q3 10-Q 2013-03-06 0001193805-13-000588
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 107.53M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 4.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 315,000 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap AccruedLiabilities Accrued Liabilities (Deprecated 2009-01-31) USD 32,667 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 187.22M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 498,000 2016-03-31 2016 Q1 10-Q 2016-05-05 0001628280-16-015744
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 4.05M 2016-09-30 2016 Q3 10-Q 2016-11-04 0001628280-16-020847
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 41.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 33.93M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 10.10M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.05M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.62B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.02B 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap AdjustmentForAmortization Amortization USD 0 2011-03-01 2011-08-31 2011 Q2 10-Q/A 2012-06-06 0001225279-12-000084
us-gaap AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD 1.36M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation USD 359,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -98,000 2021-04-01 2021-06-30 2022 Q2 10-Q 2022-08-04 0001438533-22-000032
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 338,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-06 0001438533-24-000020
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 29.86M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 771,318 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001193805-14-000998
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 12.20M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 2.42M 2015-01-01 2015-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 24.63M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium USD 91.34M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-04 0001438533-26-000063
us-gaap AdvertisingExpense Advertising Expense USD 14.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 61.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 382,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 33.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 24.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap Assets Assets USD 848.23M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AssetsCurrent Assets, Current USD 633.45M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 471.82M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2.24M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 350.51M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 202.94M 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 7,000 2016-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 1.26M 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 204.20M 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss USD 132,000 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 77.42M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 132,000 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 77.42M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 166.38M 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 348.28M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 179.83M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 168.44M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 100,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 97.10M 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares -2.51 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -61.52M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 6.99M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 88.50M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001571049-15-003959
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset USD 604,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001571049-15-006497
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -4.89M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 74.10M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 6.90M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 67.20M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Liabilities Arising from Contingencies, Amount Recognized USD 1.50M 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 116,000 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets USD 71.37M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory USD 517,000 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap BusinessDevelopment Business Development USD 300,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000650
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap Cash Cash USD 6.00M 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 3,721 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 123.54M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 123.54M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 3.48M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 123.54M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 30.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -9 2012-03-01 2012-11-30 2012 Q3 10-Q 2013-03-06 0001193805-13-000588
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 23.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 168,612 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 95.67M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 95.67M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CommonStockValue Common Stock, Value, Issued USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CommonUnitIssued Common Unit, Issued shares 401,047 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -125.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.98 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap ContractualObligation Contractual Obligation USD 100.27M 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 1.15M 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 286,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 436,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 50.00M 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 1.56M 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 436,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 2.81M 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2024-06-30 2024 Q2 10-Q 2024-08-01 0001438533-24-000031
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ConvertibleDebt Convertible Debt USD 603.51M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 300.60M 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 311.72M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 25,000 2012-05-31 2012 Q1 10-Q 2012-08-08 0001225279-12-000193
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 25.00M 2011-11-30 2011 Q3 10-Q 2012-01-11 0001225279-12-000017
us-gaap CostMethodInvestments Cost Method Investments USD 15.00M 2017-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 6.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 2.79M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 3,000 2012-02-29 2012-05-31 2012 Q1 10-Q 2012-08-08 0001225279-12-000193
us-gaap CostsAndExpenses Costs and Expenses USD 622.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 776 2011-03-02 2012-02-29 2011 FY 10-K 2012-05-24 0001225279-12-000073
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 15.71M 2018-01-01 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 988,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 988,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 2.30M 2013-06-30 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 Debt Instrument, Convertible, Threshold Consecutive Trading Days D 30 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure 1.3 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap DebtInstrumentConvertibleThresholdTradingDays Debt Instrument, Convertible, Threshold Trading Days D 20 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.077 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2013-06-30 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap DebtInstrumentRepurchaseAmount Debt Instrument, Repurchase Amount USD 23.40M 2018-09-10 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 400.87M 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 345.27M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 2.24M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 100,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 345.27M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 2.24M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DebtSecuritiesRealizedGainLoss Debt Securities, Realized Gain (Loss) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD 100,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 8.80M 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.40M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 0 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 5.70M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 56.05M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 374.04M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 27.17M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 4.85M 2017-09-30 2017 Q3 10-Q 2017-11-07 0001438533-17-000034
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 8.69M 2015-06-30 2015 Q2 10-Q 2015-08-10 0001571049-15-006497
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 130.05M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 0 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 602,000 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 2.40M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 112.09M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 13.97M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 21.73M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 370.65M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 15.89M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs USD 9 2012-12-31 2012 FY 10-K/A 2013-09-16 0001193805-13-001600
us-gaap DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs USD -610,000 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD -385 2012-12-31 2012 FY 10-K/A 2013-09-16 0001193805-13-001600
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 3.21M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 1.19M 2017-06-30 2017 Q2 10-Q 2017-08-09 0001438533-17-000029
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 184,000 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 2.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DepositAssets Deposit Assets USD 2.25M 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 244,058 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap Depreciation Depreciation USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 214,785 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 34.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -10.10M 2011-03-11 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap DerivativeLiabilities Derivative Liability USD 25.04M 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 15.70M 2017-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 129.58M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD -7.50M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap DueFromAffiliateNoncurrent Due from Affiliate, Noncurrent USD 137,547 2012-12-31 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap DueToRelatedParties Due to Related Parties (Deprecated 2009-01-31) USD 9,572 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -3.56 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.167 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.118 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure 0 2011-03-11 2011-12-31 2012 FY 10-K/A 2013-09-16 0001193805-13-001600
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.008 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.009 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.029 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.042 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.329 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap EffectOfChangeInCashFlowProjectionEstimate Effect of Change in Cash Flow Projection Estimate (Deprecated 2013-01-31) USD -49 2011-03-02 2012-02-29 2011 FY 10-K 2012-05-24 0001225279-12-000073
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD -1,177 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001571049-14-006312
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -135,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 22.13M 2011-03-11 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 8.16M 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 1.14M 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.29M 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.11M 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 12.76 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.85 2014-01-01 2014-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.014 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap FairValueEstimateNotPracticableSecuritiesSoldNotYetPurchased Fair Value, Estimate Not Practicable, Securities Sold, Not yet Purchased (Deprecated 2018-01-31) USD 1.46M 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 2.76M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 74.10M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 213.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 30.05M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 31.48M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 12.89M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 12.89M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 12.92M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 12.89M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 377.12M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 163.35M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 49,775 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 500,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 4.08M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-10-27 0001438533-22-000051
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -62,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD 204,198 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001571049-15-003959
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -7.60M 2022-03-11 2025 Q2 10-Q 2025-08-06 0001438533-25-000046
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 9,170 2012-03-01 2012-11-30 2012 Q3 10-Q 2013-03-06 0001193805-13-000588
us-gaap Goodwill Goodwill USD 800,000 2025-09-30 2025 Q3 10-Q 2025-10-30 0001438533-25-000056
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ImpairmentOfRetainedInterest Impairment of Retained Interest USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap IncentiveToLessee Incentive to Lessee USD 7.90M 2020-12-31 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -132.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -7,009 2012-02-29 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -138.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -1.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -1.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 8.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares -0.03 2012-02-29 2012-05-31 2012 Q1 10-Q 2012-08-08 0001225279-12-000193
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeTaxesPaid Income Taxes Paid USD 656,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 453,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 247,000 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -6.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 405,000 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 5.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -10.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 442,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 701,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -1.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 16.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncreaseDecreaseDueFromOtherRelatedParties Increase (Decrease) Due from Other Related Parties USD 0 2011-03-11 2013-03-31 2013 Q1 10-Q/A 2013-09-16 0001193805-13-001601
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.31M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -3.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 42.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -181,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-05 0001438533-17-000017
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.47M 2011-03-11 2012-12-31 2012 FY 10-K/A 2013-09-16 0001193805-13-001600
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 44.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 75,775 2011-03-11 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000650
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 137,547 2011-03-11 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -2,800 2012-01-01 2012-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 75,775 2011-03-11 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -849,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 6.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInLeaseAcquisitionCosts Increase (Decrease) in Lease Acquisition Costs USD -301,244 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap IncreaseDecreaseInOperatingLiabilities Increase (Decrease) in Operating Liabilities USD 200,000 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 8,781 2012-01-01 2012-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 1.69M 2011-03-11 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 2.04M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -21,830 2011-03-11 2012-12-31 2012 FY 10-K/A 2013-09-16 0001193805-13-001600
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -2.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 12.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 480,647 2011-03-11 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap IncreaseDecreaseInPrepaidTaxes Increase (Decrease) in Prepaid Taxes USD -555,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -92,956 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001571049-14-006312
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 11.39M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 39.16M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-05 0001438533-17-000017
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 10.56M 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 40.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InsuranceSettlementsReceivable Insurance Settlements Receivable USD 562,500 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 245.80M 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 164.11M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InterestAndOtherIncome Interest and Other Income USD -21,905 2011-03-11 2013-03-31 2013 Q1 10-Q/A 2013-09-16 0001193805-13-001601
us-gaap InterestExpense Interest Expense USD 2.80M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-06 0001438533-24-000020
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 6.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 1.76M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -2.80M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-06 0001438533-24-000020
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 2.56M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.07M 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap InterestPayableCurrent Interest Payable, Current USD 776,000 2016-03-31 2016 Q1 10-Q 2016-05-05 0001628280-16-015744
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 2.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 368,940 2014-09-30 2014 Q3 10-Q 2014-11-13 0001571049-14-006312
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 12.66M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryGross Inventory, Gross USD 10.52M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryLIFOReservePeriodCharge Inventory, LIFO Reserve, Period Charge USD 816,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap InventoryNet Inventory, Net USD 43.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 33.29M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 314,625 2014-09-30 2014 Q3 10-Q 2014-11-13 0001571049-14-006312
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 18.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 3.70M 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 12.38M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InventoryWriteDown Inventory Write-down USD 684,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 9.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap InvestmentsAndOtherNoncurrentAssets Investments and Other Noncurrent Assets USD 400,000 2014-09-30 2014 Q3 10-Q 2014-11-13 0001571049-14-006312
us-gaap InvestmentSoldNotYetPurchasedSaleProceeds Investment Sold, Not yet Purchased, Sale Proceeds USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 24.73M 2011-03-11 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap LandSubjectToGroundLeases Land Subject to Ground Leases sqft 4,216 2012-08-31 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 275,000 2012-08-01 2012-08-31 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap LeaseIncentiveReceivable Lease Incentive Receivable USD 7.90M 2020-12-31 2021 Q2 10-Q 2021-07-29 0001438533-21-000034
us-gaap LegalFees Legal Fees USD 0 2018-07-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001438533-18-000032
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.077 2020-02-07 2020 Q1 10-Q 2020-05-11 0001438533-20-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 13.46M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 6.98M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 4.78M 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.78M 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 4.78M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.78M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 818,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap Liabilities Liabilities USD 825.64M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 848.23M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LiabilitiesCurrent Liabilities, Current USD 210.91M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 74.10M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0001438533-24-000005
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap LongTermDebt Long-term Debt USD 46.00M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 22.60M 2018-09-30 2018 Q3 10-Q 2018-11-01 0001438533-18-000032
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 45.00M 2015-06-30 2015 Q2 10-Q 2015-08-10 0001571049-15-006497
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 46.00M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 40.80M 2015-03-31 2015 Q1 10-Q 2015-05-11 0001571049-15-003959
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 22.10M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0001438533-23-000048
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 2.00M 2015-06-01 2015-06-19 2015 Q2 10-Q 2015-08-10 0001571049-15-006497
us-gaap MarketableSecurities Marketable Securities USD 289.44M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001438533-20-000011
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 374,482 2011-03-11 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 8,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -4.39M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 219.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -33.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -304.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 27.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 115.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 92.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -124.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -102.68M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -124.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -124.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD -132.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted USD -132.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic USD 8.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted USD 8.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -37.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 0 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 884,764 2012-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 884,764 2012-12-31 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 200,000 2012-02-03 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap NumberOfBusinessesAcquired Number of Businesses Acquired business 2 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap OperatingExpenses Operating Expenses USD 62.84M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001438533-20-000011
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -101.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 12.64M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 6.31M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.33M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OperatingLeasePayments Operating Lease, Payments USD 6.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.81M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.21M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 14.03M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.34M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 2.64M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.56M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive Operating Leases, Future Minimum Payments, Due in Rolling after Year Five USD 4.22M 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearFourAndFive Operating Leases, Future Minimum Payments, Due in Rolling Year Four and Five USD 5.05M 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwoAndThree Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three USD 4.76M 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.49M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.41M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.58M 2018-12-31 2018 FY 10-K 2019-02-26 0001438533-19-000003
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 2.01M 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 138,200 2012-12-31 2012 FY 10-K/A 2013-09-16 0001193805-13-001600
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.065 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 187,000 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 29,667 2011-02-28 2011 Q2 10-Q/A 2012-06-06 0001225279-12-000084
us-gaap OtherAssets Other Assets USD 1.93M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap OtherAssetsCurrent Other Assets, Current USD 134,457 2013-03-31 2013 Q1 10-Q/A 2013-09-16 0001193805-13-001601
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 6.86M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherCommitment Other Commitment USD 4.52M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap OtherCommitmentDueAfterFifthYear Other Commitment, to be Paid, after Year Five USD 1.15M 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap OtherCommitmentDueInFifthYear Other Commitment, to be Paid, Year Five USD 286,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap OtherCommitmentDueInFourthYear Other Commitment, to be Paid, Year Four USD 436,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap OtherCommitmentDueInNextTwelveMonths Other Commitment, to be Paid, Year One USD 436,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap OtherCommitmentDueInSecondYear Other Commitment, to be Paid, Year Two USD 436,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap OtherCommitmentDueInThirdYear Other Commitment, to be Paid, Year Three USD 436,980 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent USD -219,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -0.07 2012-02-29 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 300,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap OtherExpenses Other Expenses USD 8.99M 2011-03-11 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 9.80M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap OtherLiabilities Other Liabilities USD 12.78M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 4.89M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 3.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherNoninterestExpense Other Noninterest Expense USD 8.39M 2011-03-11 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -650,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 5.96M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 42.01M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 863,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001438533-23-000039
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap PaymentsForRestructuring Payments for Restructuring USD 12.93M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 16.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001628280-16-020847
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 29.52M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 381.30M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0001438533-23-000048
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 500,000 2016-06-01 2016-06-30 2020 Q3 10-Q 2020-11-05 0001438533-20-000031
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 72.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 283.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PrepaidExpense Prepaid Expense (Deprecated 2009-01-31) USD 0 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 43.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap PrepaidTaxes Prepaid Taxes USD 1.40M 2019-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 525.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 42.92M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants USD 5.41M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000650
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 30.90M 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 2.11M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 284.60M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0001438533-23-000048
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 2.05M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 10,500 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 164.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 382.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 63.56M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 49.15M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001438533-20-000011
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 47.50M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001438533-17-000034
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 60.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 4.30M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-10-30 0001438533-19-000036
us-gaap ProfessionalFees Professional Fees USD 12,500 2014-01-01 2014-01-14 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -62.14M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.12M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.72M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 100,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap PurchaseObligation Purchase Obligation USD 8.12M 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 6,000 2012-08-31 2012 Q2 10-Q 2012-10-10 0001225279-12-000219
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 900,000 2013-01-01 2013-03-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 7.50M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0001438533-23-000048
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 187.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001438533-23-000008
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 40,000 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 40,000 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 13.80M 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 1.40M 2017-09-30 2017 Q3 10-Q 2017-11-07 0001438533-17-000034
us-gaap RestructuringCharges Restructuring Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap RestructuringCosts Restructuring Costs USD 12.40M 2023-12-01 2024-09-30 2024 Q3 10-Q 2024-10-31 0001438533-24-000048
us-gaap RestructuringReserve Restructuring Reserve USD 0 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD 200,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-24 0001438533-20-000004
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 0 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap RestructuringReserveTranslationAdjustment Restructuring Reserve, Foreign Currency Translation Gain (Loss) USD -74,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.60B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 521.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap Revenues Revenues USD 0 2012-03-01 2012-11-30 2012 Q3 10-Q 2013-03-06 0001193805-13-000588
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 34.61M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap RoyaltyExpense Royalty Expense USD 39.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 7.50M 2020-06-01 2020-06-30 2020 Q3 10-Q 2020-11-05 0001438533-20-000031
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 15.5 2020-06-30 2020 Q3 10-Q 2020-11-05 0001438533-20-000031
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 79.77M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001438533-18-000028
us-gaap SecurityDeposit Security Deposit USD 177,547 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 274.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 1.69M 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 61.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 8.50M 2011-03-11 2013-09-30 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.24 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 268,642 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 6.44 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 275,793 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 5.44 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.85 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.016 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193805-14-001682
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 154.46M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.01M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 20.37 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 90.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 103,494 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 22.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value USD/shares 4 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.03 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 238.84M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 22.56 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 238.84M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 22.56 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 4.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 20.61 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 34.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap SharePrice Share Price USD/shares 17.42 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 19 2015-03-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 2.49M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193805-14-000650
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 60.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 22.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 283.76M 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) USD 299.48M 2018-03-31 2018 Q1 10-Q 2018-07-06 0001438533-18-000022
us-gaap StockIssued1 Stock Issued USD 4.72M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-11 0001571049-15-001817
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1.25M 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-10-31 0001438533-24-000048
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 7.87M 2015-03-24 2015 Q3 10-Q 2015-11-06 0001628280-15-008436
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 15.84M 2015-01-01 2015-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 22.59M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0001438533-22-000008
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 3.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 4.40M 2012-01-01 2012-12-31 2013 Q3 10-Q/A 2015-07-09 0001571049-15-005545
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 194.16M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 59.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 6.82M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 345,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-06 0001438533-19-000024
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 130,790 2013-01-01 2013-12-31 2013 FY 10-K/A 2015-07-09 0001571049-15-005546
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 3.20M 2015-01-01 2015-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 61,000 2016-12-31 2016 FY 10-K 2017-03-01 0001438533-17-000005
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 1.15M 2017-09-30 2017 Q3 10-Q 2017-11-07 0001438533-17-000034
us-gaap TemporaryEquityForeignCurrencyTranslationAdjustments Temporary Equity, Foreign Currency Translation Adjustments USD 1.09M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001438533-21-000053
us-gaap TreasuryStockRetiredParValueMethodAmount Treasury Stock, Retired, Par Value Method, Amount USD 0 2015-01-01 2015-12-31 2017 FY 10-K 2018-07-06 0001438533-18-000020
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap TreasuryStockValue Treasury Stock, Value USD 0 2015-12-31 2015 FY 10-K 2016-02-26 0001628280-16-011857
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 26.03M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 4.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-21 0001438533-25-000010
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2017-07-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001438533-17-000034
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense Unrecognized Tax Benefits, Income Tax Penalties Expense USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001438533-18-000032
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 3.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD -1.80M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001628280-16-020847
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 26.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 26.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001438533-26-000014
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 93.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 47.54M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001438533-21-000008
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 93.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001438533-26-000077
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 959,127 2011-08-31 2011 Q2 10-Q/A 2012-06-06 0001225279-12-000084
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 3.40M 2022-03-11 2025 Q2 10-Q 2025-08-06 0001438533-25-000046

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →